Psychotic Disorders (cont.)
Roxanne Dryden-Edwards, MD
Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Melissa Conrad Stöppler, MD
Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
In this Article
- Psychotic disorder facts
- What are the different types of psychotic disorders?
- How common are psychotic disorders?
- What are causes and risk factors for psychotic disorders in children, teenagers, and adults?
- What are psychotic disorder symptoms and signs?
- How are psychotic disorders diagnosed?
- What are the treatments for psychotic disorders?
- What are potential complications of medications used to treat psychotic disorders?
- Is it possible to treat psychotic disorders without medication?
- What are complications of psychotic disorders?
- What is the prognosis for people with a psychotic disorder?
- Can psychotic disorders be prevented?
- Where can people find additional information about psychotic disorders?
- Find a local Psychiatrist in your town
What are complications of psychotic disorders?
The fact that men seem to develop these illnesses at younger ages may contribute to men having more episodes of the illness that are more severe compared to women.
What is the prognosis for people with a psychotic disorder?
While more than two-thirds of people who have a psychotic disorder may suffer a return of those symptoms at some time, the combination of medications, psychosocial treatment, and education of the psychotic disorder sufferer and their loved ones tends to greatly improve how well the person is able to function. The shorter the amount of time from when the person begins having psychotic symptoms to when comprehensive treatment begins, the better the prognosis.
Can psychotic disorders be prevented?
Cognitive behavioral therapy (CBT) for the person who is at high risk for developing psychosis but has yet to have such symptoms has been found to be more effective than medication at preventing such symptoms. In individuals who have developed psychotic symptoms, providing his or her family with support and education about their loved one's condition have been found to be quite helpful in the prevention of the recurrence of psychotic symptoms in the individual with the illness. For women who have developed postpartum psychosis in the past, preterm delivery of subsequent pregnancy has been found to help prevent further episodes of the disorder.
Where can people find additional information about psychotic disorders?
Action Postpartum Psychosis
Tel: 0292 074 2038
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
Bartholomeusz, C.F., and K. Allott. "Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: Theoretical considerations and current state of evidence." Schizophrenia Research and Treatment, 2012.
Bebbington, P., E. Kuipers, P. Garety, J. Geddes, G. Orbach, and C. Morgan. "Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy." Psychological Medicine 2002; 763-782.
Cannon, T.D., K. Cadenhead, B. Cornblatt, et al. "Prediction of psychosis in youth at high clinical risk." Archives of General Psychiatry 65 (2008): 28-37.
Cornblatt, B.A., R.E. Carrion, J. Addington, L. Seidman, E.F. Walker, et al. "Risk factors for psychosis: Impaired social and role functioning." Schizophrenia Bulletin 38.6 (2012): 1247-1257.
Das-Munshi, J., L. Becares, J.E. Boydell, M.E. Dewey, et al. "Ethnic density as a buffer for psychotic experiences: findings from a national survey (EMPIRIC)." British Journal of Psychiatry 201 Oct. 2012: 282-290.
Dvir, Y., and J.A. Frazier. "Autism and schizophrenia." Psychiatric Times 28.3 (2011).
Honey, G.D., P.R. Corlett, A.R. Absalom, M. Lee, et al. "Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo." Journal of Neuroscience June 2008: 62-95-6303.
Jenkins, R., F. Njenga, M. Okonji, P. Kigamwa, et al. "Psychotic symptoms in Kenya – prevalence, risk factors, and relationship with common mental disorders." International Journal of Environmental Research in Public Health 9.5 (2012): 1748-1756.
Malone, D.T., M.N. Hill, and T. Rubino. "Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models." British Journal of Pharmacology 160.3 June 2010: 511-522.
Nau, M.L., D.E. McNiel, and R.L. Binder. "Postpartum psychosis and the courts." Journal of the American Academy of Psychiatry and the Law 40.3 Sept. 2012: 318-325.
Nuevo, R., et al. "The continuum of psychotic symptoms in the general population: a cross-national study." Schizophrenia Bulletin 38 (2012): 475-485.
Ochoa, S., J. Usall, J. Cobo, X. Labad, and J. Kulkarni. "Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review." Schizophrenia Research and Treatment, 2012.
Semple, D.M., A.M. McIntosh, and S.M. Lawrie. "Cannabis as a risk factor for psychosis: a systemic review." Journal of Psychopharmacology 19.2 (2005): 187-194.
Shrivastava, A., P.D. McGorry, M. Tsuang, S.W. Woods, et al. "Attenuated psychotic symptoms syndrome as a risk syndrome of psychosis, diagnosis in DSM-V: The debate." Indian Journal of Psychiatry 53.1 Jan.-Mar. 2011: 57-65.
Singh, SP. "Outcome measures in early psychosis: Relevance of duration of untreated psychosis." British Journal of Psychiatry, 2007.
Stafford, M.R., et al. "Early interventions to prevent psychosis: systematic review and meta-analysis." British Medical Journal Jan. 2013: 346.
Suvisaari, J.M., V. Taxell-Lassas, M. Pankakoski, et al. "Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder." Schizophrenia Bulletin, 2012.
Terp, I.M., G. Engholm, H. Møller, and P.B. Mortensen. "A follow-up study of postpartum psychoses: prognosis and risk factors for readmission." Acta Psychiatry of Scandinavia 100 (1999): 40-46.
Valencia, M., F. Juarez, and H. Ortega. "Integrated treatment to achieve functional recovery for first-episode psychosis." Schizophrenia Research and Treatment, 2012.
Varese, F., F. Smeets, M. Drukker, R. Lieverse, et al. "Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective – and cross-sectional cohort studies." Schizophrenia Bulletin, 2012.
Wiles, N.J., S. Zammit, P. Bebbington, N. Singleton, et al. "Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey." British Journal of Psychiatry 188 (2006): 519-526.
Viewers share their comments
Get tips on therapy and treatment.